Table 1.

Participant demographics

N=34
Pseudonym	Age group	Cancer site	Treatment modality	Months post treatment
Abigail	51–55	Vulvar	Surgery and radiation	31–36
Annabelle	66–70	Uterine	Surgery and radiation	10–16
Bonnita	61–65	Cervical	Surgery and concurrent chemoradiation	10–16
Busiswa	41–45	Ovarian	Surgery	3–9
Cebisa	36–40	Cervical	Concurrent chemoradiation	3–9
Cheryl	46–50	Vulvar	Surgery and concurrent chemoradiation	24–30
Doris	66–70	Cervical	Concurrent chemoradiation	17–23
Dumisa	51–55	Cervical	Concurrent chemoradiation	10–16
Edith	61–65	Cervical	Surgery	3–9
Faith	56–60	Cervical	Surgery and concurrent chemoradiation	17–23
Fatiema	36–40	Ovarian	Surgery	17–23
Fiona	46–50	Cervical	Surgery and concurrent chemoradiation	17–23
Gia	56–60	Cervical	Concurrent chemoradiation	17–23
Grace	46–50	Vulvar	Surgery	31–36
Ivory	56–60	Uterine	Surgery	3–9
Ivy	46–50	Ovarian	Surgery and chemotherapy	17–23
Jadeen	46–50	Vulvar	Surgery	24–30
Jane	46–50	Ovarian	Surgery	24–30
Kamilieta	36–40	Cervical	Surgery and concurrent chemoradiation	10–16
Kathy	56–60	Uterine	Surgery	31–36
Kayla	51–55	Uterine	Surgery and radiation	10–16
Lucy	41–45	Cervical	Concurrent chemoradiation	17–23
Maggie	56–60	Uterine	Surgery	17–23
Nadine	51–55	Uterine	Surgery	10–16
Octavia	41–45	Uterine	Surgery and chemotherapy	3–9
Priscilla	56–60	Cervical	Concurrent chemoradiation	31–36
Roxy	51–55	Cervical	Concurrent chemoradiation	24–30
Sam	61–65	Vulvar	Surgery	10–16
Tamzin	56–60	Uterine	Surgery	10–16
Ursula	61–65	Cervical	Concurrent chemoradiation	31–36
Wendy	26–30	Ovarian	Surgery	31–36
Xoliswa	46–50	Cervical	Concurrent chemoradiation	24–30
Yvonne	41–45	Cervical	Concurrent chemoradiation	24–30
Zelda	51–55	Vulvar	Surgery	31–36